Abbott RealTime SARS-C0V-2 assay by Abbott
Manufacturer Abbott | Available Worldwide
CURBING THE COVID-19 OUTBREAK IN REALTIME
Abbott RealTime SARS-C0V-2 assay
Average Rating: 5.0
1 Scientist has reviewed this product
Status:
Reviewer
Member since: 2021
Organization: Alentic
-
- Ease of use
- After sales service
- Value for money
Awesome value
Rating: 5.0
Application Area: Diagnosis
"Exceptionally easy to use and very repeatable results"
Review date: 16 Jun 2021 | Abbott RealTime SARS-C0V-2 assay
The Abbott RealTime SARS-C0V-2 assay is an Emergency Use Authorization (EUA) test authorized by the U.S. FDA for use by authorized laboratories, using real-time (RT) polymerase chain reaction (PCR) technology for the qualitative detection of nucleic acids from the SARS-CoV-2 virus and diagnosis of SARS-CoV-2 virus infection from individuals meeting CDC clinical and/or epidemiological testing criteria.
Abbott RealTime SARS-CoV-2 assay provides a fully automated solution to help laboratories address the urgent need for automated, high-volume patient testing during the Coronavirus (COVID-19) pandemic.
The assay is engineered with:
- Dual target assay for RdRp and N-genes
- Qualitative detection of nucleic acids from SARS-CoV-2
- maxRatio data analysis removes operator subjectivity
- The Abbott RealTime SARS-CoV-2 assay in combination with the RealTime m2000 system allow scalable, automated process for flexible testing volume (24-96 samples) and up to 470 patient samples in 24 hours.
